We look forward to meeting you in person and sharing updates on our progress in bringing innovative medicine to the clinic and providing new options for cancer patients.
One-carbon therapeutics AB management at ESMO to discuss the ODIN clinical phase 1/2 trial with potential clinical sites across Europe
One-carbon therapeutics AB is discussing the ODIN trial with several
